FULL SUPPLEMENT: Real-World Clinical Experience Combining A Neuro-Peptide Serum And Botulinum Toxin Type-A Injections
By 2050, the World Health Organization (WHO) estimates that the world's population of people aged 65 years and older will have more than doubled from 761 million in 2021. As the population and their skin ages, there will be an increasing demand for targeted treatments for skin rejuvenation.
Authors
- et al
Publication Details
- Journal
- Journal of Drugs in Dermatology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.36849/jdd.436610
- Primary Topic
- Botulinum Toxin and Related Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00